175 related articles for article (PubMed ID: 34200131)
1. Expression of Neurokinin B Receptor in the Gingival Squamous Cell Carcinoma Bone Microenvironment.
Yoshida S; Shimo T; Takabatake K; Murase Y; Obata K; Okui T; Kunisada Y; Ibaragi S; Nagatsuka H; Sasaki A
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34200131
[TBL] [Abstract][Full Text] [Related]
2. Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma.
Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
Anticancer Res; 2017 Nov; 37(11):6119-6123. PubMed ID: 29061792
[TBL] [Abstract][Full Text] [Related]
3. Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas.
Ishikuro M; Sakamoto K; Kayamori K; Akashi T; Kanda H; Izumo T; Yamaguchi A
Bone; 2008 Sep; 43(3):621-7. PubMed ID: 18585993
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin B activates the formation and bone resorption activity of rat osteoclasts.
Ichiki T; Kuroishi KN; Gunjigake KK; Kobayashi S; Goto T
Neuropeptides; 2011 Jun; 45(3):239-44. PubMed ID: 21514667
[TBL] [Abstract][Full Text] [Related]
5. The Role of Sonic Hedgehog Signaling in Osteoclastogenesis and Jaw Bone Destruction.
Shimo T; Matsumoto K; Takabatake K; Aoyama E; Takebe Y; Ibaragi S; Okui T; Kurio N; Takada H; Obata K; Pang P; Iwamoto M; Nagatsuka H; Sasaki A
PLoS One; 2016; 11(3):e0151731. PubMed ID: 27007126
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Implications of Bone Invasion in Gingival Squamous Cell Carcinoma.
Yoshida S; Shimo T; Murase Y; Takabatake K; Kishimoto K; Ibaragi S; Yoshioka N; Okui T; Nagatsuka H; Sasaki A
Anticancer Res; 2018 Feb; 38(2):955-962. PubMed ID: 29374727
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma.
Chuang FH; Hsue SS; Wu CW; Chen YK
J Oral Pathol Med; 2009 Nov; 38(10):753-8. PubMed ID: 19566744
[TBL] [Abstract][Full Text] [Related]
8. Bone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway.
Goda T; Shimo T; Yoshihama Y; Hassan NM; Ibaragi S; Kurio N; Okui T; Honami T; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2615-23. PubMed ID: 20682990
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma.
Okura M; Yanamoto S; Umeda M; Otsuru M; Ota Y; Kurita H; Kamata T; Kirita T; Yamakawa N; Yamashita T; Ueda M; Komori T; Hasegawa T; Aikawa T;
Cancer Med; 2016 Dec; 5(12):3378-3385. PubMed ID: 27758080
[TBL] [Abstract][Full Text] [Related]
10. Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin.
Sarau HM; Mooney JL; Schmidt DB; Foley JJ; Buckley PT; Giardina GA; Wang DY; Lee JA; Hay DW
Mol Pharmacol; 2000 Sep; 58(3):552-9. PubMed ID: 10953048
[TBL] [Abstract][Full Text] [Related]
11. Two different protein expression profiles of oral squamous cell carcinoma analyzed by immunoprecipitation high-performance liquid chromatography.
Kim SM; Jeong D; Kim MK; Lee SS; Lee SK
World J Surg Oncol; 2017 Aug; 15(1):151. PubMed ID: 28789700
[TBL] [Abstract][Full Text] [Related]
12. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma.
Jimi E; Furuta H; Matsuo K; Tominaga K; Takahashi T; Nakanishi O
Oral Dis; 2011 Jul; 17(5):462-8. PubMed ID: 21496184
[TBL] [Abstract][Full Text] [Related]
13. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of preprotachykinin A and B transcripts in the bovine corpus luteum and evidence for functional neurokinin receptor activity in luteal endothelial cells and ovarian macrophages.
Brylla E; Aust G; Geyer M; Uckermann O; Löffler S; Spanel-Borowski K
Regul Pept; 2005 Feb; 125(1-3):125-33. PubMed ID: 15582723
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive markers for perineural and bone invasion of oral squamous cell carcinoma.
Michalek J; Brychtova S; Pink R; Dvorak Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):302-308. PubMed ID: 31435075
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin Receptor 3 Distribution in Human Oral Squamous Cell Carcinoma.
Obata K; Shimo T; Okui T; Matsumoto K; Takada H; Takabatake K; Kunisada Y; Ibaragi S; Nagatsuka H; Sasaki A
Anticancer Res; 2016 Dec; 36(12):6335-6341. PubMed ID: 27919954
[TBL] [Abstract][Full Text] [Related]
18. Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus.
Lévesque M; Parent R; Parent A
Eur J Neurosci; 2006 May; 23(10):2760-72. PubMed ID: 16817879
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the prognostic role of pSTAT3 expression in temporal bone squamous cell carcinoma.
Marioni G; Nucci R; Marino F; Cappellesso R; Pillon M; Zanoletti E; Giacomelli L; Franchella S; Billo P; Pareschi R; Martini A
Otol Neurotol; 2013 Oct; 34(8):1476-82. PubMed ID: 24005169
[TBL] [Abstract][Full Text] [Related]
20. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
